Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
The issue related to macrovascular outcomes and intensive glycemic control was hotly debated after the publication of landmark trials like ACCORD, ADVANCE, and VADT. The only benefits seem to come from intervening early on in the disease process as indicated by the 10-year UKPDS follow-up. To compli...
Saved in:
Main Authors: | Samit Ghosal, Binayak Sinha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2016/1643496 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular Safety of Clonidine and Dexmedetomidine in Critically Ill Patients after Cardiac Surgery
by: Angelina Grest, et al.
Published: (2020-01-01) -
Long-term cardiovascular outcomes after percutaneous coronary intervention in patients with systemic sclerosis
by: Kazutoshi Hirose, et al.
Published: (2025-04-01) -
Tea in cardiovascular health and disease: a critical appraisal of the evidence
by: Klaus W. Lange
Published: (2022-05-01) -
Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis
by: Ting Zhang, et al.
Published: (2025-01-01) -
Cardiovascular Profile and Cardiovascular Imaging After Bariatric Surgery: A Narrative Review
by: Mihaela Toader, et al.
Published: (2025-01-01)